Angiotensin Metabolism

Product #


Biochem/physiol Actions

Add to Cart

A5855 Abz-LFK(Dnp)-OH trifluoroacetate salt ≥97% (HPLC) Abz-LFK(Dnp)-OH is an Angiotensin Converting Enzyme (ACE) fluorescent peptide substrate specific for the C domain for real time fluorescent assay (ACE, Peptidyl Dipeptidase, Kininase II, E.C.
A0773 Angiotensin Converting Enzyme Inhibitor ≥95% (TLC)  
E6888 Enalapril maleate salt powder, ≥98% (TLC) A long-acting angiotensin-converting enzyme inhibitor.
E9658 Enalaprilat dihydrate ≥98% (HPLC) Enalapril, the ethyl ester of enalaprilat exhibits slight pharmacological activity until it is hydrolyzed in the liver to enalaprilat. Enalaprilat, a IV form of an angiotensin-converting-enzyme inhibitor (ACE) prevents the transformation of angiotensin I to angiotensin II, a potent vasoconstrictor.
Enalaprilat is an inhibitor of angiotensin converting enzyme (ACE), antihypertensive, and a Bradykinin B1 receptor activator. Enalaprilat has nM potency versus ACE and also activates B1 receptors to release NO.
F7131 N-[3-(2-Furyl)acryloyl]-Phe-Gly-Gly  
H4884 Hippuryl-His-Leu acetate salt Substrate for angiotensin converting enzyme.
H1635 N-Hippuryl-His-Leu hydrate powder, ≥98% (HPLC)  
SML0148 Imidapril hydrochloride ≥98% (HPLC) Imidapril hydrochloride is a long-acting inhibitor of angiotensin converting enzyme used in the treatment of hypertension, congestive heart failure and diabetic nephropathy. It restores decreased airway sensation and bladder sensation in patients with multiple sclerosis.
Imidapril is a potent angiotensin converting enzyme inhibitor and anti-hypertensive.
SML1391 Olmesartan medoxomil ≥98% (HPLC) Olmesartan medoxomil is a selective Angiotensin II Type I receptor blocker and antihypertensive drug. Olmesartan medoxomil is converted enzymatically to the active form olmesartan.
Olmesartan medoxomil is considered as an antihypertensive agent. It is an angiotensin 2 type 1 antagonist receptor. It is a prodrug which releases the parent compound olmesartan after ingestion. Olmesartan is ejected via kidney and liver. In humans, olmesartan protects renal and cardiovascular systems. This drug may be used in the treatment of hypertension.